Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Caliper Life Sciences, a provider of tools and services for drug discovery and life sciences research, has introduced the LabChip XT, an automated nucleic acid fractionation instrument.
Subscribe to our email newsletter
The solution removes a key bottleneck in the current workflow for sequencing by replacing the tedious gel isolation and purification steps used for size selection of sheared genomic DNA. The LabChip XT and its integrated software utilise a multi-channel microfluidic chip to quickly process samples independently and without the potential for cross contamination.
Kevin Hrusovsky, president and CEO of Caliper Life Sciences, said: “The LabChip XT was developed in collaboration with sequencing centers and providers of sequencing instrumentation and chemistries. We are confident that the LabChip XT, the first product Caliper is introducing to the sequencing market, will improve sample preparation efficiency and downstream data processing two critical elements for sequencing.
“We are collaborating with our newly formed Sequencing Science Advisory Board to demonstrate these sequencing workflow improvements as well as to develop additional technology platforms in this sector.”